Relationship between number, timing, and type of pharmacist interventions and patient outcomes

American Journal of Health-System Pharmacy

Volumn 62, Issue 17, 2005, Pages 1798-1801

  Charrois, Theresa L ^a   Johnson, Jeffrey A ^a   Blitz, Sandra ^a   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; OUTCOMES RESEARCH; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 24144432926     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040421     Document Type: Article

References (11)

1. Tsuyuki RT, Johnson JA, Teo KK et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002; 162:1149-55.
2. Park IJ, Kelly P, Carter BL et al. Comprehensive pharmaceutical care in the chain setting: drug therapy monitoring and counseling by pharmacists contributed to improved blood pressure control in study patients. J Am Pharm Assoc. 1996; NS36: 443-51.
3. McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003; 10:195-202.
4. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003; 25:144-53.
5. Carter BL, Barnette DJ, Chrischilles E et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997; 17:1274-85.
6. Cording M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001; 21:1196-203.
7. Ellis SL, Carter BL, Malone DC et al. Clinical and economic impact of ambulatory care clinical pharmacists in the management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy. 2000; 20:1508-16.
8. Weinberger M, Oddone EZ, Henderson WG et al. Multisite randomized controlled trials in health services research: scientific challenges and operational issues. Med Care. 2001; 39:627-34.
9. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airway disease: a randomized controlled trial. JAMA. 2002; 288:1594-602.
10. Tsuyuki RT, Olson KL, Dubyk AM et al. Evaluation of a comprehensive community pharmacist intervention program on cholesterol reduction in patients at high risk for cardiovascular events: SCRIP-plus. Am J Med. 2004; 116:130-3.
11. Fodor JG, Frohlich JJ, Genest JJ et al. Recommendations for the management and treatment, of dyslipidemia. Can Med Assoc J. 2000; 162:1441-7.